Evidence map›Paper›PMID 28505632›Full record

Observational studyAnnals of internal medicine2017

Missed Opportunities for Measles, Mumps, Rubella Vaccination Among Departing U.S. Adult Travelers Receiving Pretravel Health Consultations.

Emily P Hyle, Sowmya R Rao, Emily S Jentes, Amy Parker Fiebelkorn, Stefan H F Hagmann, Allison Taylor Walker, Rochelle P Walensky, Edward T Ryan, Regina C LaRocque

Open access · bronzeAbstract readMulticenter StudyObservational Study
PubMed Full text at PMC Publisher
In one paragraph

Observational study in Annals of internal medicine, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed, 1 pooled it
4.5field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 1 synthesis or guideline pooled it, 29 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

9 authors at 1 institution in 1 country.

Emily P HyleFrom Massachusetts General Hospital, Harvard Medical School, and Boston University, Boston, Massachusetts; Centers for Disease Control and Prevention, Atlanta, Georgia; Bronx Lebanon Hospital Center, Bronx, New York; and Icahn School of Medicine at Mount Sinai, New York, New York.
Sowmya R RaoFrom Massachusetts General Hospital, Harvard Medical School, and Boston University, Boston, Massachusetts; Centers for Disease Control and Prevention, Atlanta, Georgia; Bronx Lebanon Hospital Center, Bronx, New York; and Icahn School of Medicine at Mount Sinai, New York, New York.
Emily S JentesFrom Massachusetts General Hospital, Harvard Medical School, and Boston University, Boston, Massachusetts; Centers for Disease Control and Prevention, Atlanta, Georgia; Bronx Lebanon Hospital Center, Bronx, New York; and Icahn School of Medicine at Mount Sinai, New York, New York.
Amy Parker FiebelkornFrom Massachusetts General Hospital, Harvard Medical School, and Boston University, Boston, Massachusetts; Centers for Disease Control and Prevention, Atlanta, Georgia; Bronx Lebanon Hospital Center, Bronx, New York; and Icahn School of Medicine at Mount Sinai, New York, New York.
Stefan H F HagmannFrom Massachusetts General Hospital, Harvard Medical School, and Boston University, Boston, Massachusetts; Centers for Disease Control and Prevention, Atlanta, Georgia; Bronx Lebanon Hospital Center, Bronx, New York; and Icahn School of Medicine at Mount Sinai, New York, New York.
Allison Taylor WalkerFrom Massachusetts General Hospital, Harvard Medical School, and Boston University, Boston, Massachusetts; Centers for Disease Control and Prevention, Atlanta, Georgia; Bronx Lebanon Hospital Center, Bronx, New York; and Icahn School of Medicine at Mount Sinai, New York, New York.
Rochelle P WalenskyFrom Massachusetts General Hospital, Harvard Medical School, and Boston University, Boston, Massachusetts; Centers for Disease Control and Prevention, Atlanta, Georgia; Bronx Lebanon Hospital Center, Bronx, New York; and Icahn School of Medicine at Mount Sinai, New York, New York.
Edward T RyanFrom Massachusetts General Hospital, Harvard Medical School, and Boston University, Boston, Massachusetts; Centers for Disease Control and Prevention, Atlanta, Georgia; Bronx Lebanon Hospital Center, Bronx, New York; and Icahn School of Medicine at Mount Sinai, New York, New York.
Regina C LaRocqueFrom Massachusetts General Hospital, Harvard Medical School, and Boston University, Boston, Massachusetts; Centers for Disease Control and Prevention, Atlanta, Georgia; Bronx Lebanon Hospital Center, Bronx, New York; and Icahn School of Medicine at Mount Sinai, New York, New York.
Bronx-Lebanon Hospital Center · US

Funding

Global TravEpiNet: Global Travelers' Health National Research Center ConsortiumU19CI000514 · CI · MASSACHUSETTS GENERAL HOSPITAL · PI RYAN, EDWARD T. · 2007 to 2010
$2.3M
Cardiovascular Disease in South African HIV Patients: Value of PreventionK01HL123349 · NHLBI · MASSACHUSETTS GENERAL HOSPITAL · PI HYLE, EMILY PARKER · 2016 to 2020
$896k
NCEZID CDC HHS U01 CK000175NCEZID CDC HHS U01 CK000490NCPDCID CDC HHS U19 CI000514NHLBI NIH HHS K01 HL123349
6 · The paper itself

Abstract

Background: Measles outbreaks continue to occur in the United States and are mostly due to infections in returning travelers. Objective: To describe how providers assessed the measles immunity status of departing U.S. adult travelers seeking pretravel consultation and to assess reasons given for nonvaccination among those considered eligible to receive the measles, mumps, rubella (MMR) vaccine. Design: Observational study in U.S. pretravel clinics. Setting: 24 sites associated with Global TravEpiNet (GTEN), a Centers for Disease Control and Prevention-funded consortium. Patients: Adults (born in or after 1957) attending pretravel consultations at GTEN sites (2009 to 2014). Measurements: Structured questionnaire completed by traveler and provider during pretravel consultation. Results: 40 810 adult travelers were included; providers considered 6612 (16%) to be eligible for MMR vaccine at the time of pretravel consultation. Of the MMR-eligible, 3477 (53%) were not vaccinated at the visit; of these, 1689 (48%) were not vaccinated because of traveler refusal, 966 (28%) because of provider decision, and 822 (24%) because of health systems barriers. Most MMR-eligible travelers who were not vaccinated were evaluated in the South (2262 travelers [65%]) or at nonacademic centers (1777 travelers [51%]). Nonvaccination due to traveler refusal was most frequent in the South (1432 travelers [63%]) and in nonacademic centers (1178 travelers [66%]). Limitation: These estimates could underrepresent the opportunities for MMR vaccination because providers accepted verbal histories of disease and vaccination as evidence of immunity. Conclusion: Of U.S. adult travelers who presented for pretravel consultation at GTEN sites, 16% met criteria for MMR vaccination according to the provider's assessment, but fewer than half of these travelers were vaccinated. An increase in MMR vaccination of eligible U.S. adult travelers could reduce the likelihood of importation and transmission of measles virus. Primary Funding Source: Centers for Disease Control and Prevention, National Institutes of Health, and the Steve and Deborah Gorlin MGH Research Scholars Award.

Indexed as

MeaslesMeasles-Mumps-Rubella VaccineMumpsRubellaTravelVaccinationAdultDisease OutbreaksFemaleHumansMaleReferral and ConsultationTreatment RefusalUnited StatesMeasles-Mumps-Rubella Vaccine

Identifiers

PMID28505632
PMCPMC5513758
OpenAlexW2614134627

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.